CBS News @CBSNews
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare autoimmune diseases, in a deal valued at $26.4 billion. https://t.co/yRGZR2NLLY — PolitiTweet.org
Created
Mon Dec 12 15:15:00 +0000 2022
Likes
13
Retweets
8
Source
Sprinklr
View Raw Data
JSON DataView on Twitter
Likely Available
CBS News @CBSNews
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare autoimmune diseases, in a deal valued at $26.4 billion. https://t.co/yRGZR2NLLY — PolitiTweet.org